Central Bank & Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.77M | Buy |
11,017
+8,905
| +422% | +$1.92M | 0.39% | 63 |
|
|
2026
Q1 | $459K | Buy |
2,112
+150
| +8% | +$33.3K | 0.07% | 142 |
|
|
2025
Q4 | $448K | Sell |
1,962
-274
| -12% | -$62.4K | 0.07% | 137 |
|
|
2025
Q3 | $518K | Buy |
2,236
+149
| +7% | +$30.3K | 0.08% | 134 |
|
|
2025
Q2 | $387K | Sell |
2,087
-29
| -1% | -$5.39K | 0.06% | 146 |
|
|
2025
Q1 | $443K | Buy |
2,116
+5
| +0.2% | +$972 | 0.07% | 141 |
|
|
2024
Q4 | $375K | Sell |
2,111
-1,235
| -37% | -$227K | 0.06% | 149 |
|
|
2024
Q3 | $661K | Hold |
3,346
| – | – | 0.09% | 134 |
|
|
2024
Q2 | $574K | Hold |
3,346
| – | – | 0.08% | 128 |
|
|
2024
Q1 | $609K | Sell |
3,346
-68
| -2% | -$11.7K | 0.09% | 128 |
|
|
2023
Q4 | $529K | Buy |
3,414
+1,692
| +98% | +$247K | 0.08% | 136 |
|
|
2023
Q3 | $257K | Hold |
1,722
| – | – | 0.04% | 153 |
|
|
2023
Q2 | $232K | Buy |
1,722
+108
| +7% | +$15.8K | 0.04% | 160 |
|
|
2023
Q1 | $257K | Sell |
1,614
-422
| -21% | -$64.5K | 0.05% | 156 |
|
|
2022
Q4 | $329K | Sell |
2,036
-101
| -5% | -$15.5K | 0.06% | 149 |
|
|
2022
Q3 | $287K | Buy |
2,137
+287
| +16% | +$41.2K | 0.06% | 150 |
|
|
2022
Q2 | $283K | Buy |
1,850
+106
| +6% | +$16.2K | 0.06% | 161 |
|
|
2022
Q1 | $283K | Buy |
1,744
+211
| +14% | +$30.6K | 0.05% | 157 |
|
|
2021
Q4 | $208K | Buy |
1,533
+500
| +48% | +$59.1K | 0.03% | 167 |
|
|
2021
Q3 | $111K | Hold |
1,033
| – | – | 0.02% | 186 |
|
|
2021
Q2 | $116K | Hold |
1,033
| – | – | 0.02% | 187 |
|
|
2021
Q1 | $112K | Hold |
1,033
| – | – | 0.02% | 180 |
|
|
2020
Q4 | $111K | Buy |
1,033
+100
| +11% | +$9.61K | 0.02% | 171 |
|
|
2020
Q3 | $82K | Buy |
933
+200
| +27% | +$18.8K | 0.02% | 177 |
|
|
2020
Q2 | $72K | Hold |
733
| – | – | 0.01% | 170 |
|
|
2020
Q1 | $56K | Sell |
733
-500
| -41% | -$42.6K | 0.01% | 171 |
|
|
2019
Q4 | $109K | Sell |
1,233
-23
| -2% | -$1.91K | 0.02% | 160 |
|
|
2019
Q3 | $95K | Sell |
1,256
-433
| -26% | -$29.7K | 0.02% | 164 |
|
|
2019
Q2 | $123K | Sell |
1,689
-4,444
| -72% | -$349K | 0.03% | 152 |
|
|
2019
Q1 | $494K | Sell |
6,133
-2,178
| -26% | -$178K | 0.11% | 108 |
|
|
2018
Q4 | $766K | Buy |
8,311
+187
| +2% | +$16.4K | 0.19% | 88 |
|
|
2018
Q3 | $768K | Buy |
8,124
+366
| +5% | +$34.7K | 0.18% | 87 |
|
|
2018
Q2 | $719K | Sell |
7,758
-139
| -2% | -$13.6K | 0.18% | 83 |
|
|
2018
Q1 | $747K | Buy |
7,897
+675
| +9% | +$74.2K | 0.19% | 82 |
|
|
2017
Q4 | $698K | Buy |
7,222
+31
| +0.4% | +$2.92K | 0.17% | 95 |
|
|
2017
Q3 | $639K | Buy |
7,191
+67
| +0.9% | +$5.1K | 0.16% | 95 |
|
|
2017
Q2 | $517K | Sell |
7,124
-782
| -10% | -$52.6K | 0.13% | 102 |
|
|
2017
Q1 | $515K | Buy |
7,906
+4,370
| +124% | +$275K | 0.13% | 101 |
|
|
2016
Q4 | $222K | Sell |
3,536
-129
| -4% | -$7.87K | 0.06% | 131 |
|
|
2016
Q3 | $231K | Sell |
3,665
-32
| -0.9% | -$2.07K | 0.06% | 121 |
|
|
2016
Q2 | $228K | Sell |
3,697
-448
| -11% | -$27.3K | 0.07% | 121 |
|
|
2016
Q1 | $236K | Sell |
4,145
-451
| -10% | -$25.1K | 0.07% | 119 |
|
|
2015
Q4 | $272K | Buy |
4,596
+54
| +1% | +$3.11K | 0.08% | 112 |
|
|
2015
Q3 | $247K | Buy |
4,542
+1,434
| +46% | +$93.3K | 0.08% | 108 |
|
|
2015
Q2 | $208K | Buy |
3,108
+1,149
| +59% | +$75K | 0.07% | 115 |
|
|
2015
Q1 | $115K | Buy |
1,959
+500
| +34% | +$30.2K | 0.04% | 144 |
|
|
2014
Q4 | $95K | Buy |
1,459
+300
| +26% | +$18.9K | 0.03% | 152 |
|
|
2014
Q3 | $67K | Buy |
1,159
+759
| +190% | +$42.1K | 0.03% | 159 |
|
|
2014
Q2 | $22K | Hold |
400
| – | – | 0.01% | 198 |
|
|
2014
Q1 | $20K | Hold |
400
| – | – | 0.01% | 207 |
|
|
2013
Q4 | $22K | Hold |
400
| – | – | 0.01% | 198 |
|
|
2013
Q3 | $18K | Hold |
400
| – | – | 0.01% | 211 |
|
|
2013
Q2 | $17.5K | Buy |
+400
| New | +$17.5K | 0.01% | 215 |
|
Other funds holding ABBV
Central Bank & Trust's ABBV Position: Q2 2026 in Review
Central Bank & Trust increased its AbbVie (ABBV) stake by 422% in Q2 2026, buying an estimated $1.92M and bringing the position to 11,017 shares worth $2.77M. The position accounts for 0.39% of the portfolio, ranked #63.
Central Bank & Trust first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Central Bank & Trust held 11,017 shares of AbbVie worth $2.77M as of Q2 2026.
- Central Bank & Trust bought 8,905 AbbVie shares in Q2 2026, an estimated $1.92M.
- AbbVie made up 0.39% of Central Bank & Trust's portfolio in Q2 2026, its #63 holding.
- Central Bank & Trust first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Central Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.